Skip to content

ZLAB

Zai Lab Ltd.

NASDAQ · Healthcare · Biotechnology · CN

$24.06
+3.75%
Ask drillr

Year over year

Reported trailing growth

Revenue
+5.1%
EBITDA
+12.5%
EBIT
-6.9%
EPS
+69.8%
Free cash flow
+28.5%
Operating cash flow
+23.9%

Forward estimates

Based on analyst estimates

Revenue
+7.3%
EBITDA
-27.1%
EPS
-20.8%

Three-year CAGR

Revenue
+28.9%
EBITDA
+34.9%
EBIT
+20.8%
Net income
+31.7%
EPS
+38.5%
Free cash flow
+40.6%

Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Jun 1, 2026